These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 34405782

  • 21. Regulation of drugs and devices: an evolution.
    Merrill RA.
    Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161
    [Abstract] [Full Text] [Related]

  • 22. The FDA's humanitarian device exemption program.
    Eydelman MB, Chen EA.
    Health Aff (Millwood); 2011 Jun; 30(6):1210-2; author reply 1212. PubMed ID: 21653975
    [No Abstract] [Full Text] [Related]

  • 23. Gastroenterology-urology devices; effective date of requirement for premarket approval of the penile inflatable implant. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr 12; 65(71):19650-8. PubMed ID: 11010632
    [Abstract] [Full Text] [Related]

  • 24. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD, Rathi VK, Teng CC, Del Priore L, Ross JS.
    Ophthalmology; 2017 Aug 12; 124(8):1237-1246. PubMed ID: 28501378
    [Abstract] [Full Text] [Related]

  • 25. The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.
    Mottes LM.
    Seton Hall Law Rev; 2011 Aug 12; 41(2):723-63. PubMed ID: 21739761
    [No Abstract] [Full Text] [Related]

  • 26. Regulatory aspects of invasive glucose measurements.
    Gutman S, Bernhardt P, Pinkos A, Moxey-Mims M, Knott T, Cooper J.
    Diabetes Technol Ther; 2002 Aug 12; 4(6):775-7. PubMed ID: 12685800
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Off-label use of medical devices in radiology: regulatory standards and recent developments.
    Smith JJ.
    J Am Coll Radiol; 2010 Aug 12; 7(2):115-9. PubMed ID: 20142085
    [Abstract] [Full Text] [Related]

  • 29. FDA recognition of consensus standards in the premarket notification program.
    Marlowe DE, Phillips PJ.
    Biomed Instrum Technol; 1998 Aug 12; 32(3):301-4. PubMed ID: 9619259
    [Abstract] [Full Text] [Related]

  • 30. Ensuring medical device effectiveness and safety: a cross--national comparison of approaches to regulation.
    Kramer DB, Tan YT, Sato C, Kesselheim AS.
    Food Drug Law J; 2014 Aug 12; 69(1):1-23, i. PubMed ID: 24772683
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. FDA's new regulatory paradigms for in vitro diagnostic devices.
    Robinowitz M, Gutman SI.
    Cytotherapy; 1999 Aug 12; 1(4):353-7. PubMed ID: 20426566
    [No Abstract] [Full Text] [Related]

  • 33. How many testers are needed to assure the usability of medical devices?
    Borsci S, Macredie RD, Martin JL, Young T.
    Expert Rev Med Devices; 2014 Sep 12; 11(5):513-25. PubMed ID: 25033757
    [Abstract] [Full Text] [Related]

  • 34. Integrated Devices: A New Regulatory Pathway to Promote Revolutionary Innovation.
    Cho T, Gowda V, Schulzrinne H, Miller BJ.
    Milbank Q; 2024 Jun 12; 102(2):367-382. PubMed ID: 38253988
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG, Zuckerman DM.
    Milbank Q; 2017 Sep 12; 95(3):535-553. PubMed ID: 28895231
    [Abstract] [Full Text] [Related]

  • 38. Pharmaceuticals and Medical Devices: FDA Oversight.
    White RS, Thomson Reuters Accelus..
    Issue Brief Health Policy Track Serv; 2017 Dec 26; 2017():1-33. PubMed ID: 29361662
    [No Abstract] [Full Text] [Related]

  • 39. Medical devices; 30-day notices and 135-day PMA (premarket approval application) supplement review--FDA. Direct final rule.
    Fed Regist; 1998 Apr 27; 63(80 Pt 1):20530-3. PubMed ID: 10179319
    [Abstract] [Full Text] [Related]

  • 40. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST, Pippins RR, Ngai JW.
    Food Drug Law J; 2009 Apr 27; 64(3):577-98. PubMed ID: 19999646
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.